News
CRYSTAL: Cetuximab Combined with Irinotecan in First Line Therapy for Metastatic Colorectal Cancer; HR: Hazard ratio; FOLFIRI: Folinic acid and fluorouracil-based regimen containing irinotecan ...
Cetuximab is a monoclonal antibody with activity against colorectal cancers that overexpress epidermal growth factor receptor. This agent blocks epidermal growth factor receptor signaling and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback